Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

472
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
472

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Postoperative PSA Dynamics and Prognostic Implications After Radical Prostatectomy.

Cancers·2026
Same author

Current Challenges and Needs of Clinical Laboratories in the Asia-Pacific Region: A Cross-Country Assessment.

The journal of applied laboratory medicine·2026
Same author

Aberrant Plasma Cells in the Absence of M-Protein: Ancillary Testing beyond Protein Electrophoresis.

Clinical chemistry·2025
Same author

Prostate cancer in men under 50: the impact of race/ethnicity and family history.

Annals of medicine·2025
Same author

Persistent AST Elevation in a Patient With Ovarian Cancer: A Rare Diagnostic Challenge.

Journal of clinical laboratory analysis·2025
Same author

Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same journal

Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.

Pathogens (Basel, Switzerland)·2026
Same journal

Ventilator-Associated Pneumonia (VAP) Prevention Bundle: A Multicenter Cross-Sectional Saudi Study to Assess Knowledge, Adherence, and Perceived Barriers Among ICU Practitioners in Hail Region.

Pathogens (Basel, Switzerland)·2026
Same journal

Anti-<i>Borrelia</i> IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case-Control Study from Northern Türkiye.

Pathogens (Basel, Switzerland)·2026
Same journal

Molecular Characterization of Hemotropic <i>Mycoplasma</i> spp. From Bats (Chiroptera) in the Northern Pantanal, Brazil.

Pathogens (Basel, Switzerland)·2026
Same journal

Characterization of Durum-Einkorn Amphiploids for Introgression of Powdery Mildew Resistance from Einkorn into Common Wheat.

Pathogens (Basel, Switzerland)·2026
Same journal

Human Orthohantavirus Infections: A Narrative Review.

Pathogens (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K

Advancing Laboratory Diagnostics for Future Pandemics: Challenges and Innovations.

Lechuang Chen1, Qing H Meng1

  • 1Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 37, Houston, TX 77030, USA.

Pathogens (Basel, Switzerland)
|November 27, 2025
PubMed
Summary
This summary is machine-generated.

Recent epidemics highlight the need for advanced diagnostics. A multi-layered system combining molecular techniques, antigen tests, serology, NGS, and point-of-care testing is crucial for global health security.

Keywords:
COVID-19EbolaH1N1pdm09SARSdiagnostic technologiesepidemicpandemics

More Related Videos

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

1.2K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.1K

Related Experiment Videos

Last Updated: Jan 10, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

1.2K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.1K

Area of Science:

  • Epidemiology and Public Health
  • Infectious Disease Diagnostics
  • Biotechnology

Background:

  • Major epidemics (SARS, H1N1pdm09, Ebola, COVID-19) exposed critical weaknesses in traditional disease diagnostic systems, including long turnaround times and supply chain issues.
  • There is a pressing need for advanced diagnostic technologies and integrated strategies to improve global disease surveillance and control.
  • Lessons learned from recent outbreaks underscore the limitations of existing diagnostic models and the necessity for innovation.

Purpose of the Study:

  • To review key lessons from four major outbreaks regarding diagnostic challenges.
  • To highlight advancements in diagnostic technologies relevant to epidemic and pandemic response.
  • To propose a future framework for global diagnostic networks.

Main Methods:

  • Review of literature and case studies from recent major outbreaks.
  • Analysis of molecular diagnostic techniques: loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), recombinase polymerase amplification (RPA), and droplet digital polymerase chain reaction (ddPCR).
  • Evaluation of antigen testing, serological assays, next-generation sequencing (NGS), and point-of-care testing (POCT) advancements.

Main Results:

  • Molecular techniques offer significant advantages for pathogen detection.
  • Antigen testing is vital for rapid screening in community settings.
  • Serological assays are valuable for retrospective analysis and immunity assessment.
  • Next-generation sequencing (NGS) aids in novel pathogen identification and mutation monitoring.
  • Point-of-care testing (POCT), enhanced by AI and biosensing, extends diagnostic capabilities to the front lines.

Conclusions:

  • The future of epidemic and pandemic response relies on a multi-layered, complementary diagnostic system, not a single technology.
  • Integrating laboratory diagnostics, distributed screening, and real-time monitoring is essential.
  • A global diagnostic network is necessary for rapid response and preparedness against future health crises.